$3.55 Billion is the total value of RTW INVESTMENTS, LP's 77 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 33.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | $351,885,000 | +50.0% | 16,812,491 | 0.0% | 9.90% | -1.9% | |
| ALNY | Alnylam Pharmaceuticals Inc | $249,068,000 | +36.1% | 1,681,645 | 0.0% | 7.01% | -11.1% | |
| PTCT | Buy | PTC Therapeutics Inc | $201,089,000 | +14.6% | 3,963,120 | +0.8% | 5.66% | -25.1% |
| DRNA | Buy | Dicerna Pharmaceuticals Inc | $181,684,000 | +42.0% | 7,152,918 | +2.7% | 5.11% | -7.2% |
| ADVM | Buy | Adverum Biotechnologies Inc | $141,776,000 | +118.8% | 6,790,027 | +2.4% | 3.99% | +43.0% |
| IMVT | Buy | Immunovant Inc | $139,213,000 | +111.3% | 5,717,182 | +29.2% | 3.92% | +38.1% |
| AXSM | Buy | Axsome Therapeutics Inc | $136,446,000 | +120.3% | 1,658,316 | +57.5% | 3.84% | +44.0% |
| MRTX | Buy | Mirati Therapeutics Inc | $124,186,000 | +64.0% | 1,087,726 | +10.4% | 3.49% | +7.2% |
| RNA | New | Avidity Biosciences Inc | $103,863,000 | – | 3,995,000 | +100.0% | 2.92% | – |
| MYOK | Buy | Myokardia Inc | $90,526,000 | +147.3% | 936,931 | +20.0% | 2.55% | +61.6% |
| MASI | Buy | Masimo Corp | $88,637,000 | +30.7% | 388,776 | +1.5% | 2.49% | -14.6% |
| STOK | Stoke Therapeutics Inc | $84,459,000 | +4.1% | 3,544,248 | 0.0% | 2.38% | -32.0% | |
| BAX | New | Baxter Intl Inc | $83,463,000 | – | 969,370 | +100.0% | 2.35% | – |
| CERN | New | Cerner Corp | $81,054,000 | – | 1,182,409 | +100.0% | 2.28% | – |
| NTRA | Buy | Natera Inc | $76,242,000 | +101.7% | 1,529,128 | +20.8% | 2.14% | +31.8% |
| TBIO | Buy | Translate Bio Inc | $66,609,000 | +80.9% | 3,716,994 | +0.7% | 1.87% | +18.2% |
| RLMD | Buy | Relmada Therapeutics Inc | $66,268,000 | +97.3% | 1,480,852 | +50.4% | 1.86% | +28.9% |
| AXNX | Buy | Axonics Modulation Technolog | $66,121,000 | +52.3% | 1,883,257 | +10.2% | 1.86% | -0.5% |
| FIXX | Sell | Homology Medicines Inc | $66,110,000 | -3.3% | 4,352,190 | -1.1% | 1.86% | -36.8% |
| BLU | Buy | Bellus Health Inc New | $61,550,000 | +12.5% | 5,970,230 | +8.7% | 1.73% | -26.5% |
| PTGX | Buy | Protagonist Therapeutics Inc | $59,747,000 | +218.1% | 3,383,208 | +27.2% | 1.68% | +108.0% |
| TNDM | Buy | Tandem Diabetes Care Inc | $59,245,000 | +107.5% | 598,923 | +35.0% | 1.67% | +35.6% |
| TXG | Buy | 10x Genomics Inc | $56,809,000 | +379.5% | 636,092 | +234.6% | 1.60% | +213.3% |
| OYST | Buy | Oyster Pt Pharma Inc | $55,142,000 | +62.5% | 1,909,360 | +96.9% | 1.55% | +6.2% |
| VCEL | Sell | Vericel Corp | $53,212,000 | +30.1% | 3,850,347 | -13.7% | 1.50% | -15.0% |
| AGEN | Sell | Agenus Inc | $50,558,000 | +57.6% | 12,864,677 | -1.8% | 1.42% | +3.0% |
| FREQ | Buy | Frequency Therapeutics Inc | $50,255,000 | +36.2% | 2,161,486 | +4.4% | 1.41% | -11.0% |
| ESTA | Establishment Labs Hldgs Inc | $43,322,000 | +29.3% | 2,319,138 | 0.0% | 1.22% | -15.5% | |
| AVDL | Buy | Avadel Pharmaceuticals plcsponsored adr | $42,877,000 | +18.3% | 5,306,570 | +14.9% | 1.21% | -22.7% |
| Buy | DermTech Inc | $37,782,000 | +29.9% | 2,855,765 | +9.8% | 1.06% | -15.1% | |
| MGNX | New | MacroGenics Inc | $34,783,000 | – | 1,245,816 | +100.0% | 0.98% | – |
| CLDX | New | Celldex Therapeutics Inc New | $33,930,000 | – | 2,610,000 | +100.0% | 0.96% | – |
| ISEE | New | IVERIC bio Inc | $33,642,000 | – | 6,596,536 | +100.0% | 0.95% | – |
| CSTL | Buy | Castle Biosciences Inc | $30,284,000 | +45.5% | 803,510 | +15.1% | 0.85% | -4.9% |
| PRQR | Buy | ProQR Thrapeutics N V | $29,809,000 | +13.6% | 4,902,785 | +2.6% | 0.84% | -25.7% |
| NSTG | Sell | NanoString Technologies Inc | $27,798,000 | +9.1% | 947,134 | -10.6% | 0.78% | -28.7% |
| ADAP | New | Adaptimmune Therapeutics PLCsponds adr | $26,026,000 | – | 2,600,000 | +100.0% | 0.73% | – |
| WVE | Sell | WAVE Life Sciences Ltd | $24,885,000 | -21.7% | 2,390,496 | -29.5% | 0.70% | -48.8% |
| ODT | Buy | Odonate Therapeutics Inc | $20,367,000 | +101.5% | 481,027 | +31.4% | 0.57% | +31.7% |
| STAA | Sell | STAAR Surgical Co | $19,010,000 | -12.8% | 308,904 | -54.3% | 0.54% | -43.0% |
| APYX | Apyx Med Corp | $18,822,000 | +54.6% | 3,391,279 | 0.0% | 0.53% | +1.1% | |
| OSUR | New | OraSure Technologies Inc | $17,922,000 | – | 1,540,972 | +100.0% | 0.50% | – |
| JNJ | Buy | Johnson & Johnson | $17,840,000 | +16.4% | 126,858 | +8.6% | 0.50% | -23.9% |
| TELA | Buy | Tela Bio Inc | $17,682,000 | +98.5% | 1,364,358 | +19.7% | 0.50% | +29.4% |
| MIST | Milestone Pharmaceuticals In | $16,311,000 | +105.4% | 4,315,102 | 0.0% | 0.46% | +34.2% | |
| XGN | Sell | Exagen Inc | $15,576,000 | -22.2% | 1,255,131 | -0.0% | 0.44% | -49.2% |
| MDXG | MiMedx Group Inc | $14,582,000 | +54.7% | 2,700,320 | 0.0% | 0.41% | +1.0% | |
| NEO | New | Neogenomics Inc | $13,786,000 | – | 445,000 | +100.0% | 0.39% | – |
| GNMK | New | GenMark Diagnostics Inc | $13,757,000 | – | 935,206 | +100.0% | 0.39% | – |
| CTMX | Buy | Cytomx Therapeutics Inc | $12,616,000 | +54.2% | 1,514,476 | +42.0% | 0.36% | +0.9% |
| ABUS | Arbutus Biopharma Corp | $12,502,000 | +80.2% | 6,869,281 | 0.0% | 0.35% | +17.7% | |
| AMRS | New | Amyris Inc | $12,401,000 | – | 3,103,535 | +100.0% | 0.35% | – |
| RGNX | Buy | Regenxbio Inc | $11,639,000 | +14.6% | 316,028 | +0.8% | 0.33% | -25.2% |
| LJPC | Buy | La Jolla Pharmaceutical Co | $10,117,000 | +2.3% | 2,374,952 | +0.9% | 0.28% | -33.1% |
| TMDX | Transmedics Group Inc | $9,019,000 | +48.4% | 503,266 | 0.0% | 0.25% | -3.1% | |
| ITMR | Itamar Med Ltdsponsored ads | $8,504,000 | +57.9% | 457,218 | 0.0% | 0.24% | +3.0% | |
| CLSD | Buy | Clearside Biomedical Inc | $7,365,000 | +11.6% | 3,917,622 | +0.9% | 0.21% | -27.1% |
| ARGX | argenx SEsponsored adr | $7,152,000 | +71.0% | 31,752 | 0.0% | 0.20% | +11.7% | |
| QURE | Buy | Uniqure NV | $7,087,000 | -4.3% | 157,282 | +0.8% | 0.20% | -37.6% |
| INMD | Inmode Ltd | $7,080,000 | +31.7% | 250,000 | 0.0% | 0.20% | -13.9% | |
| RPTX | New | Repare Therapeutics Inc | $6,980,000 | – | 225,000 | +100.0% | 0.20% | – |
| BWAY | Brainsway Ltdsponsored ads | $6,556,000 | -25.4% | 1,107,420 | 0.0% | 0.18% | -51.3% | |
| ARVN | Sell | Arvinas Inc | $5,840,000 | -58.0% | 174,118 | -49.5% | 0.16% | -72.6% |
| ARYBU | New | ARYA Sciences Acquistion Counit 06/09/2027 | $5,798,000 | – | 500,000 | +100.0% | 0.16% | – |
| LSACU | Lifesci Acquisition Corpunit 03/31/2025 | $5,500,000 | +10.0% | 500,000 | 0.0% | 0.16% | -27.9% | |
| CHAQU | New | Chardan Healthcr Acqstn 2 Counit 99/99/9999 | $3,675,000 | – | 350,000 | +100.0% | 0.10% | – |
| PHGE | Biomx Inc | $3,312,000 | -21.1% | 600,000 | 0.0% | 0.09% | -48.6% | |
| PSNL | Personalis Inc | $3,307,000 | +60.7% | 255,000 | 0.0% | 0.09% | +4.5% | |
| PROF | Profound Med Corp | $2,951,000 | +73.9% | 174,193 | 0.0% | 0.08% | +13.7% | |
| PROG | New | Progenity Inc | $2,475,000 | – | 275,000 | +100.0% | 0.07% | – |
| NARI | New | Inari Med Inc | $2,173,000 | – | 44,860 | +100.0% | 0.06% | – |
| FLGT | Fulgent Genetics Inc | $1,200,000 | +48.7% | 75,000 | 0.0% | 0.03% | -2.9% | |
| MOTS | Motus Gi Hldgs Inc | $1,024,000 | +95.8% | 775,640 | 0.0% | 0.03% | +26.1% | |
| TWST | Buy | Twist Bioscience Corp | $837,000 | +78.5% | 18,473 | +20.5% | 0.02% | +20.0% |
| BNR | New | Burning Rock Biotech Ltdsponsored ads | $810,000 | – | 30,000 | +100.0% | 0.02% | – |
| VRAY | Viewray Inc | $336,000 | -10.4% | 150,000 | 0.0% | 0.01% | -43.8% | |
| PHGEWS | BiomX Inc*w exp 10/16/202 | $287,000 | -20.3% | 600,000 | 0.0% | 0.01% | -46.7% | |
| Exit | Vivus Inc 4.5 05/01/2020note4.500% 5/0 | $0 | – | -4,000,000 | -100.0% | -0.13% | – | |
| GBT | Exit | Global Blood Therapeutics In | $0 | – | -719,489 | -100.0% | -1.58% | – |
| SRPT | Exit | Sarepta Therapeutics Inc | $0 | – | -529,261 | -100.0% | -2.23% | – |
| ZBH | Exit | Zimmer Biomet Holdings Inc | $0 | – | -671,457 | -100.0% | -2.92% | – |
| BMY | Exit | Bristol-Myers Squibb Co | $0 | – | -1,685,934 | -100.0% | -4.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.